awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38016956-0900E9CB-7C58-43E3-A42A-5225942DBF5E
Q38016956-0900E9CB-7C58-43E3-A42A-5225942DBF5E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38016956-0900E9CB-7C58-43E3-A42A-5225942DBF5E
Pharmacologic interventions for hidradenitis suppurativa: what does the evidence say?
P2860
Q38016956-0900E9CB-7C58-43E3-A42A-5225942DBF5E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38016956-0900E9CB-7C58-43E3-A42A-5225942DBF5E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4c7e33d7f8291c41d3d0d5167473fbfa00aa5f68
P2860
Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial.